Slight respiratory irritation but not inflammation in mice exposed to (1 → 3)-β-D-glucan aerosols

Mediators of Inflammation

Volumn 12, Issue 3, 2003, Pages 139-146

  Korpi, A ^a   Kasanen, J P ^a   Kosma, V M ^b,c   Rylander, R ^d   Pasanen, A L ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Fungal cell wall component; Grifolan; Inhalation exposure; Mice

Indexed keywords

BETA 1,3 GLUCAN; IMMUNOGLOBULIN E;

AEROSOL; AIRWAY DYNAMICS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; FEMALE; FUNGUS IMMUNITY; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; INHALATION; LUNG DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SENSITIZATION; SYMPTOMATOLOGY;

AEROSOLS; ANIMALS; BETA-GLUCANS; FEMALE; GLUCANS; IMMUNIZATION; IMMUNOGLOBULIN E; LUNG; MALE; MICE; MICE, INBRED BALB C; RESPIRATORY MECHANICS; RESPIRATORY SYSTEM; STACHYBOTRYS; TIME FACTORS;

ANIMALIA; FUNGI;

EID: 0037765341     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/0962935031000134851     Document Type: Article

References (42)

1. Burge H. Bioaerosols: Prevalence and health effects in the indoor environment. J Allergy Clin Immunol 1990; 86: 687-701.
2. Flannigan B, McCabe EM, McGarry F. Allergenic and toxigenic microorganisms in houses. J Appl Bacteriol 1991; 70: 61s-73s.
3. Rylander R, Persson K, Goto H, Yuasa K, Tanaka S. Airborne beta-1,3-glucan may be related to symptoms in sick buildings. Indoor Environ 1992; 1: 263-267.
4. Ruotsalainen R, Jaakkola N, Jaakkola JJK. Dampness and molds in daycare centers as an occupational health problem. Int Arch Occup Environ Health 1995; 66: 369-374.
5. Rylander R, Lin R-H. (1 → 3)-β-D-glucan - relationship to indoor air-related symptoms, allergy and asthma. Toxicology 2000; 152: 47-52.
6. Wan G-H, Li C-S. Indoor endotoxin and glucan in association with airways inflammation and systemic symptoms. Arch Environ Health 1999; 54: 172-179.
7. Rylander R. Airway responsiveness and chest symptoms after inhalation of endotoxin or (1 → 3)-β-D-glucan. Indoor Built Environ 1996; 5: 106-111.
8. American Society for Testing and Materials. Standard Test Method for Estimating Sensory Irritancy of Airborne Chemicals. Designation E 981-84. Philadelphia, PA: American Society for Testing and Materials, 1984.
9. Korpi A, Kasanen J-P, Raunio P, Kosma V-M, Virtanen T, Pasanen A-L Effects of aerosols from non-toxic Stachybotrys chartarum on murine airways. Inhal Toxicol 2002; 14: 521-540.
10. Schaper M. Development of a database for sensory irritants and its use in establishing occupational exposure limits. Am Ind Hyg Assoc J 1993; 54: 488-544.
11. Adachi Y, Okazaki M, Ohno N, Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1 → 3)-β-D-glucan, Grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 1994; 17: 1554-1560.
12. Ohno N, Adachi Y, Suzuki I, Sato K, Oikawa S, Yadomae T. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull 1986; 34: 1709-1715.
13. Thorn J, Rylander R. Airways inflammation and glucan in a rowhouse area. Am J Respir Crit Care Med 1998; 157: 1798-1803.
14. Boylstein LA, Andersson SJ, Thompson RD, Alarie Y. Characterization of the effects of an airborne mixture of chemicals on the respiratory tract and smoothing polynomial spline analysis of the data. Arch Toxicol 1995; 69: 579-589.
15. Vijayaraghavan R, Schaper M, Thompson R, Stock MF, Alarie Y. Characteristic modifications of the breathing pattern of mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch Toxicol 1993; 67: 478-490.
16. Vijayaraghavan R, Schaper M, Thompson R, Stock MF, Boylstein LA, Luo JE, Alarie Y. Computer assisted recognition and quantitation of the effects of airborne chemicals acting at different areas of the respiratory tract in mice. Arch Toxicol 1994; 68: 490-499.
17. Popp JA, Monteiro-Riviere NA. Macroscopic, microscopic, and ultrastructural anatomy of the nasal cavity, rat; the upper respiratory system (nares, larynx, trachea). In: Jones TC, Mohr U, Hunt RD, eds. Monographs on Pathology of Laboratory Animals, sponsored by the International Life Sciences Institute. Respiratory System, Berlin: Springer-Verlag, 1985: 3-4.
18. Alarie Y. Computer-based bioassay for evaluation of sensory irritation of airborne chemicals and its limit of detection. Arch Toxicol 1998; 72: 277-282.
19. Boylstein LA, Luo J, Stock MF, Alarie Y. An attempt to define a just detectable effect for airborne chemicals on the respiratory tract in mice. Arch Toxicol 1996; 70: 567-578.
20. Raabe OG, Al-Bayati MA, Teague SV, Rasolt A. Regional deposition of inhaled monodisperse coarse and fine aerosol panicles in small laboratory animals. Ann Occup Hyg 1988; 32(Suppl 1): 53-63.
21. Lewis TR, Morrow PE, McClellan RO, et al. Establishing aerosol exposure concentrations for inhalation toxicity studies. Toxicol Appl Pharmacol 1989; 99: 377-383.
22. Dales RE, Burnett R, Zwanenburg H. Adverse health effects among adults exposed to home dampness and molds. Am Rev Respir Dis 1991; 143: 505-509.
23. Dales RE, Zwanenburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol 1991; 134: 196-203.
24. Jaakkola JJK, Jaakkola N, Ruotsalainen R. Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expo Anal Environ Epidemiol 1993; 3(Suppl 1): 129-142.
25. Björnsson E, Norbäck D, Janson C, Widström J, Palmgren U, Ström G, Boman G. Asthmatic symptoms and indoor levels of micro-organisms and house dust mites. Clin Exp Allergy 1995; 25:423-431.
26. Garrett MH, Rayment PR, Hooper MA, Abramson MJ, Hooper BM. Indoor airborne fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 1998; 28: 459-467.
27. Rylander R. Investigations of the relationship between disease and airborne (1 → 3)-β-D-glucan in buildings. Mediat Inflamm 1997; 6: 275-277.
28. Fogelmark B, Lacey J, Rylander R. Experimental allergic alveolitis after exposure to different microorganisms. Int J Exp Pathol 1991; 72: 387-395.
29. Fogelmark B, Sjöstrand M, Rylander R. Pulmonary inflammation induced by repeated inhalations of β(1,3)-D-glucan and endotoxin. Int J Exp Pathol 1994; 75: 85-90.
30. Robinson VA, Frazer DG, Afshari AA, Goldsmith WT, Olenchock S, Whitmer MP, Castranova V. Guinea pig response to zymosan and a serial exposure of zymosan and endotoxin. In: Jacobs RR, Wakelyn PJ, Rylander R, eds. Proceedings of the 20th Cotton and Organic Dust Research Conferences, Nashville, TN: National Cotton Council, 1996: 356-360.
31. Fogelmark B, Sjöstrand M, Williams D, Rylander R. Inhalation toxicity of (1 → 3)-β-D-glucan: recent advances. Mediat Inflamm 1997; 6: 263-265.
32. Schuyler M, Gott K, Cherne A. Effect of glucan on murine lungs. J Toxicol Environ Health 1998; 53: 493-505.
33. Young S-H, Robinson VA, Barger M, Porter DW, Frazer DG, Castranova V. Acute inflammation and recovery in rats after intratracheal instillation of a 1 → 3-β-glucan (zymosan A). J Toxicol Environ Health A 2001; 64: 311-325.
34. Young S-H, Robinson VA, Barger M, Frazer DG, Castranova V. Particulate 1 → 3-β-glucan is the more potent form for inducing pulmonary inflammation in rats [abstract]. Toxicologist 2002; 66: 354.
35. Okazaki M, Adachi Y, Ohno N, Yadomae T. Structure-activity relationship of (1 → 3)-β-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol Pharm Bull 1995; 18: 1320-1327.
36. Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T. Effect of β-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol Pharm Bull 1996; 19: 608-612.
37. Ishibashi K, Miura NN, Adachi Y, Ohno N, Yadomae T. Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci Biotechnol Biochem 2001; 65: 1993-2000.
38. Young S-H, Ye J, Frazer DG, Shi X, Castranova V. Molecular mechanism of tumor necrosis factor-α production in 1 → 3-β-glucan (zymosan)-activated macrophages. J Biol Chem 2001; 276: 20781-20787.
39. Adachi Y, Suzuki Y, Ohno N, Yadomae T. Adjuvant effect of grifolan on antibody production in mice. Biol Pharm Bull 1998; 21: 974-977.
40. Wan G-H, Li C-S, Guo S-P, Rylander R, Lin R-H. An airborne mold-derived product, β-1,3-D-glucan, potentiates airway allergic responses. Eur J Immunol 1999; 29: 2491-2497.
41. Ormstad H, Groeng E-C, Løvik M, Hetland G. The fungal cell wall component β-1,3-glucan has an adjuvant effect on the allergic response to ovalbumin in mice. J Toxicol Environ Health Part A 2000; 61: 55-67.
42. Suzuki Y, Adachi Y, Ohno N, Yadomae T. Th1/Th2-balancing immunomodulating activity of gel-forming (1 → 3)-beta-glucans from fungi. Biol Pharm Bull 2001; 24: 811-819.